Generali Asset Management’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.56M Sell
92,974
-2,034
-2% -$94.6K 0.1% 196
2025
Q4
$4.14M Sell
95,008
-40,456
-30% -$1.85M 0.08% 209
2025
Q3
$6.1M Buy
135,464
+2,354
+2% +$103K 0.13% 145
2025
Q2
$5.78M Buy
133,110
+27,252
+26% +$1.21M 0.13% 160
2025
Q1
$4.88M Buy
105,858
+30,838
+41% +$1.29M 0.12% 177
2024
Q4
$2.82M Buy
+75,020
New +$2.91M 0.07% 261

Other funds holding EXC

Generali Asset Management's EXC Position: Q1 2026 in Review

Generali Asset Management reduced its Exelon (EXC) stake by 2.1% in Q1 2026, selling an estimated $94.6K and leaving 92,974 shares worth $4.56M. The position accounts for 0.1% of the portfolio, ranked #196.

Generali Asset Management first reported a position in EXC in Q4 2024 and has held it in 6 quarters since. The position peaked at $6.1M in Q3 2025. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Generali Asset Management held 92,974 shares of Exelon worth $4.56M as of Q1 2026.
  • Generali Asset Management sold 2,034 Exelon shares in Q1 2026, an estimated $94.6K.
  • Exelon made up 0.1% of Generali Asset Management's portfolio in Q1 2026, its #196 holding.
  • Generali Asset Management first reported a position in Exelon in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's Exelon position peaked at $6.1M in Q3 2025.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.